Ernesto Moran, MD | |
400 Turnpike St, Susquehanna, PA 18847-1638 | |
(570) 853-3135 | |
(570) 853-3008 |
Full Name | Ernesto Moran |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 400 Turnpike St, Susquehanna, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841234325 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD028862L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ernesto Moran, MD 400 Turnpike St, Susquehanna, PA 18847-1638 Ph: (570) 853-3135 | Ernesto Moran, MD 400 Turnpike St, Susquehanna, PA 18847-1638 Ph: (570) 853-3135 |
News Archive
The childhood obesity epidemic in the United States has been growing for decades. A new study focusing on African-American children shows how the issue can also impact social development. The University of Cincinnati study led by Laura Nabors, an associate professor of health promotion and education, will be featured in a poster presentation on Nov. 2, at the 143rd American Public Health Association Annual Meeting and Expo, in Chicago.
Like breathing or blinking, behaviors regulated by our circadian rhythms, such as digestion and sleep-wake cycles, go unnoticed by most people.
OncoGenex Pharmaceuticals, Inc. announced today that results from a retrospective analysis of the Phase 3 SYNERGY trial showed a benefit with custirsen therapy in men with metastatic castrate-resistant prostate cancer (CRPC) who had a poor prognosis.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the University of Massachusetts Medical School have developed a strategy to treat two of the most common inherited blood diseases - sickle cell disease and beta thalassemia - applying CRISPR-Cas9 gene editing to patients' own blood stem cells.
Legislative leaders in search of momentum on health reform "conceded that they did not have an immediate strategy for advancing a health care measure and described their time frame as open-ended," The New York Times reports.
› Verified 5 days ago